Dermal Filler Market Report 2025

The dermal filler market size has grown rapidly in recent years. It will grow from $6.57 billion in 2024 to $7.24 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to expanding aesthetic industry, advancements in injection technique, celebrity endorsements and influence, focus on anti-aging solutions, rise in minimally invasive procedures.

The dermal filler market size is expected to see rapid growth in the next few years. It will grow to $11.13 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to market expansion in emerging economies, customized and personalized treatments, biodegradable and bioresorbable fillers, focus on longevity and durability. Major trends in the forecast period include biodegradable fillers, advanced formulations, non-invasive procedures, customizable treatments, longer lasting results.

The rising number of aesthetic procedures performed by plastic surgeons is anticipated to drive growth in the dermal filler market. Aesthetic procedures focus on enhancing the appearance of the face and body, reflecting a growing emphasis on beauty and body image as forms of identity and self-expression. Dermal fillers are primarily utilized in plastic surgery and aesthetic treatments to create a smoother and fuller facial appearance. For instance, in June 2024, a report from the Aesthetic Society, a US-based professional organization, indicated that the number of breast implant removal procedures rose to 74,326 in 2023, up from 65,076 in 2022, marking a 14.2% increase. Consequently, the increasing frequency of aesthetic procedures conducted by plastic surgeons is expected to propel the growth of the dermal filler market.

The growth of the dermal filler market in the coming years is anticipated to be driven by the increase in the aging population. This demographic trend refers to a higher proportion of elderly individuals within a population, often measured by an increase in the median age. Dermal fillers are commonly utilized by the aging population as a non-surgical method to address visible signs of aging. These injectable gels enhance skin volume, helping to smooth out wrinkles, plump lips, and restore lost contours. For example, a report from ReliefWeb, a US-based humanitarian information platform that houses over a million humanitarian crisis reports, news releases, evaluations, recommendations, assessments, maps, and infographics, indicated in July 2022 that the percentage of the global population aged 65 and older is projected to rise from 10% in 2022 to 16% by 2050. By 2050, the number of individuals aged 65 and above is expected to surpass twice that of children under five and will be approximately equal to that of children under twelve. Thus, the increasing aging population is propelling the dermal filler market forward.

Key players in the dermal filler market are concentrating on developing advanced formulations, such as under-eye hyaluronic acid (HA) dermal fillers, to stimulate market growth. Under-eye HA dermal fillers are gel-like injectable treatments specifically formulated to restore volume, alleviate hollowness, and reduce dark circles in the under-eye area, utilizing hyaluronic acid to boost hydration and achieve a natural look. For example, in June 2023, Galderma, a dermatology company based in Switzerland, introduced Restylane Eyelight, the first and only hyaluronic acid (HA) dermal filler in the U.S. that employs NASHA Technology. This product offers results lasting up to 18 months, providing a natural-looking enhancement with minimal crosslinking and a gel texture that resists water absorption. Supported by a Phase 3 clinical study, Restylane Eyelight showed that 87% of patients experienced reduced under-eye hollowness after three months, with high satisfaction rates sustained for over a year.for lip enhancement. MaiLi uses 24% less product for the same volumizing effect.

Prominent companies operating in the dermal filler market are developing innovative products such as lip augmentation fillers to enhance product offerings and gain a competitive advantage. Lip augmentation fillers are employed to change the size and form of the lips, usually by injecting fillers such as hyaluronic acid or collagen. Allergan Aesthetics received FDA approval in February 2022 for JUVÉDERM VOLBELLA XC for infraorbital hollow treatment, expanding its product offering and launching a comprehensive training program for clinicians.

In October 2022, Prollenium Medical Technologies, a Canada-based medical technology company that manufactures dermal fillers, acquired SoftFil for an undisclosed amount. Both firms are dedicated to increasing the safety and efficacy of cosmetic medical operations. The shared objective of the SoftFil and Revanesse brands was a deciding factor in this transaction. The goal of Prollenium's purchase is to maintain the SoftFil brand's independence and character while also strengthening its international presence via the development of creative interconnections between both brands, SoftFil and Revanesse. SoftFil is a France-based company that manufactures dermal fillers, micro-cannulas, and innovative cosmetics.

Major companies operating in the dermal filler market include Merz Pharma GmbH & Co. KGaA, Laboratoires Vivacy, Bloomage Biotechnology Corporation Limited, Teoxane Laboratories, Sinclair Pharma, Anika Therapeutics Inc., Croma-Pharma GmbH, Revance Therapeutics Inc., BioPlus Co. Ltd., Hans Biomed Corp., Regen Lab SA, Prollenium Medical Technologies Inc., Scivision Biotech Inc, Hyaltech Ltd., Bioxis Pharmaceuticals, Suneva Medical Inc., Bohus BioTech AB, Medy Tox Inc, Galderma S.A., Sculpt Fillers, Sylagen.

North America was the largest region in the dermal filler market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dermal filler market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the dermal filler market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Dermal fillers, injected beneath the skin, help correct wrinkles, restore facial volume, and enhance facial features.

Dermal fillers come in various types such as calcium hydroxylapatite, hyaluronic acid, poly-alkylimide, polylactic acid, and polymethylmethacrylate microspheres. Calcium Hydroxylapatite fillers are particularly effective for addressing moderate-to-severe creases such as nasolabial folds, marionette lines, and frown lines, also enhancing cheek fullness and other facial contours. These fillers can be biodegradable or non-biodegradable and serve multiple applications including scar treatment, wrinkle correction, lip enhancement, and restoring facial volume. End users benefiting from these treatments include hospitals, cosmetic clinics, outpatient centers, beauty centers, and various other medical facilities offering cosmetic procedures.

The dermal fillers market research report is one of a series of new reports that provides dermal filler market statistics, including dermal filler industry global market size, regional shares, competitors with a dermal filler market share, detailed dermal filler market segments, market trends and opportunities, and any further data you may need to thrive in the dermal filler industry. This dermal filler market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

The dermal filler market consists of sales of autologous fat injections, permanent soft tissue filler. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.